VXRT stock forecast
Our latest prediction for Vaxart Inc's stock price was made on the May 22, 2020 when the stock price was at 2.91$.
In the short term (2weeks), VXRT's stock price should outperform the market by 0.87%. During that period the price should oscillate between -12.74% and +17.02%.
In the medium term (3months), VXRT's stock price should underperform the market by -5.16%. During that period the price should oscillate between -39.99% and +37.39%.Get email alerts
Create a solid portfolio with VXRT
About Vaxart Inc
Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. Vaxart has a collaborative development program for oral delivery of a vaccine against universal flu using proprietary antigens from Janssen Pharmaceutica .
At the moment the company generates 7M USD in revenues.
On its last earning announcement, the company reported a loss of -0.70$ per share.
The book value per share is 3.13$
Three months stock forecastMay 22, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|